Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis

BACKGROUND: A Phase I, single-center investigation found that 8 weeks of antimycobacterial therapy improved sarcoidosis FVC. Safety and efficacy assessments have not been performed in a multicenter cohort. RESEARCH QUESTION: The objective of this study was to determine the safety and efficacy of ant...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Chest
Huvudupphovsmän: Drake, Wonder P., Culver, Daniel A., Baughman, Robert P., Judson, Marc A., Crouser, Elliott D., James, W. Ennis, Ayers, Gregory D., Ding, Tan, Abel, Kenny, Green, Abena, Kerrigan, Amy, Sesay, Ahmed, Bernard, Gordon R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American College of Chest Physicians 2021
Ämnen:
Diffuse Lung Disease: Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129732/
https://ncbi.nlm.nih.gov/pubmed/33387486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.12.027
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk